N/A N=130 Functional Status, Morbidity and Mortality in Cemented Versus Press-Fit Hemiarthroplasty
Femoral Neck Fracture
Primary: Mortality — 23.1; 20.1 pecent
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=62 PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS
Myelodysplastic Syndromes
Primary: The Primary Objective of the Trial is to Assess the Efficacy of the Combined Use of Valproic Acid (VPA) in Combination With 5-Azacytidine (5-Aza C) in the Treatment of…
Phase 1 N=34 Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia (AML)
Leukaemia, Myelocytic, Acute
Primary: Number of Patients With Severe Toxicities — 1; 1; 1; 1 Participants
Phase 2 N=24 Evaluating the Impact of JJVC Senofilcon A - Based Contact Lens With New UV-blocker on Day and Night Driving Performance
Visual Performance
Primary: Overall Nighttime Driving Score — -0.308; -0.375; -0.430 Z-Score
N/A N=206 Determination of Abnormal Fetal Growth or Amniotic Fluid With Third Trimester Ultrasounds in Uncomplicated Pregnancies: A Randomized Trial
Uncomplicated Pregnancy · Abnormal Fetal Growth or Fluid
Primary: Number of Participants With Fetal Growth Restriction — 2; 8 Participants
Phase 1 N=63 A Combination Therapy Study of MK-2206 and AZD6244 in Participants With Advanced Solid Tumors (MK-2206-010)
Locally Advanced or Metastatic Solid Tumors
Primary: Number of Participants With a Dose-limiting Toxicity (DLT) — 0; 2; 2; 1 Participants
Phase 4 N=85 Perineural Steroids for Peripheral Nerve Blocks
Osteoarthritis, Knee
Primary: Duration of Sensory Nerve Block — 37.00; 31.75; 29.67 hours
N/A N=52 Chest Wall Oscillation for Asthma and COPD Exacerbations Trial (COAT)
Asthma · Chronic Obstructive Pulmonary Disease (COPD) · Undifferentiated Asthma/COPD
Primary: Patient Adherence to High Frequency Chest Wall Oscillation — 93; 91 Percent of 60 minutes prescribed
N/A N=50 Comparison of Two Behavioral Treatments for Stress Reduction
Stress
Primary: Brain Activity (fMRI) During the Body Scan Meditation — 74; 82 voxels
Phase 2 N=120 Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation
Leukemia · Lymphoma · Allogeneic Haematopoietic Stem Cell Transplantation
Primary: Treatment-Related Mortality (TRM) Defined as Non Relapse Mortality (NRM) — 10 percentage of participants
Phase 1 N=17 Randomized Trial Comparing Sitagliptin to Placebo in Closed Loop
Diabetes Mellitus, Type 1
Primary: Blood Glucose Measures in Subjects Treated With Sitagliptin, Compared to the Placebo — 149.7; 155.9 mg/dl
N/A N=10 Closed-Loop Insulin Delivery in Children Less Than 7 Years of Age
Type 1 Diabetes Mellitus
Primary: Nocturnal Glycemic Control — 3.2; 5.3 Hours — p=0.12
Phase 2 N=65 Bortezomib and Vorinostat in Treating Patients With Recurrent Mantle Cell Lymphoma or Recurrent and/or Refractory Diffuse Large B-Cell Lymphoma
Recurrent Mantle Cell Lymphoma · Recurrent Non-Hodgkin Lymphoma
Primary: Overall Response Rate (ORR) — 31.8; 0; 7.7 percentage of participants
N/A N=47 Use of Track Health Function of the MyHealthevet Personal Health Record
Prediabetic State
Primary: Change From Baseline Weight — 225.0; 222.1 lbs. — p=.003
N/A N=131 Effects of Neuromuscular Blockade Level and Intra-abdominal Pressure on Surgical Conditions and Cardiopulmonary Responses During Laparoscopic Colon Surgery With the Trendelenburg Position
Cardiac Index
Primary: Cardiac Index — 2.6; 2.7; 2.7 L/min/m^2